
Black Swan Analysis has appointed Christopher Ehinger as managing director.He moves to the company from GE Healthcare, where he served as oncology …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

